Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 17, 2015. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2014. Go to the latest filing (Q3 2026)

21.8B USDQ4 2014
Total value of stock positions
21.8B USD
Positions
62
Share of the ten largest
46.5%

The ten largest positions Q4 2014

  1. Illumina, Inc. 7.0%▼ −4.1%
  2. Walgreens Boots Alliance Inc 6.6%new
  3. Valeant Pharmaceuticals Intl 6.0%▼ −8.9%
  4. Actavis PLC 5.4%▲ +79.8%
  5. Pioneer Nat Res Co 4.5%▼ −2.9%
  6. Canadian Pac Ry Ltd 3.6%▲ +107.6%
  7. Air Products 3.5%▲ +50.8%
  8. Thermo Fisher Scientific 3.3%▼ −27.5%
  9. Micron Technology 3.2%▼ −2.0%
  10. Cheniere Energy Inc 3.2%▲ +82.5%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2014

Positions Q4 2014 per 13F filing, 20 of 20
Symbol Weight Shares Reported value Change Held since
Valeant Pharmaceuticals Intl 6.0% 9,077,007 1.3B USD −8.9% reduced Q2 2013 or earlier 7 quarters
TMO Thermo Fisher Scientific 3.3% 5,786,510 725.0M USD −27.5% reduced Q2 2013 or earlier 7 quarters
MU Micron Technology 3.2% 20,163,744 705.9M USD −2.0% reduced Q2 2013 or earlier 7 quarters
MA Mastercard 1.7% 4,304,154 370.8M USD −67.0% reduced Q2 2013 or earlier 7 quarters
LYB LyondellBasell 1.5% 4,049,281 321.5M USD −43.2% reduced Q2 2013 or earlier 7 quarters
V Visa Inc. 1.1% 916,606 240.3M USD −69.8% reduced Q2 2013 or earlier 7 quarters
Alexion Pharmaceuticals Inc 0.3% 390,271 72.2M USD −82.2% reduced Q2 2013 or earlier 7 quarters
ILMN Illumina, Inc. 7.0% 8,293,405 1.5B USD −4.1% reduced Q4 2013 5 quarters
Mohawk Inds Inc 2.8% 3,952,060 614.0M USD −30.4% reduced Q4 2013 5 quarters
Acadia Pharmaceuticals Inc 0.4% 2,956,266 93.9M USD −31.6% reduced Q4 2013 5 quarters
Pioneer Nat Res Co 4.5% 6,586,936 980.5M USD −2.9% reduced Q1 2014 4 quarters
Kansas City Southern 1.8% 3,197,766 390.2M USD −24.9% reduced Q1 2014 4 quarters
Salix Pharmaceuticals Inc 0.9% 1,738,104 199.8M USD −36.1% reduced Q1 2014 4 quarters
Allergan Inc 1.9% 1,966,112 418.0M USD −13.8% reduced Q2 2014 3 quarters
Newfield Expl Co < 0.1% 767,638 20.8M USD −91.5% reduced Q2 2014 3 quarters
C Citigroup 2.8% 11,220,274 607.1M USD −24.7% reduced Q3 2014 2 quarters
BNY BNY Mellon 2.2% 11,866,061 481.4M USD −29.1% reduced Q3 2014 2 quarters
Google Inc 1.8% 742,461 394.0M USD −19.6% reduced Q3 2014 2 quarters
BABA Alibaba Group (ADR) 1.8% 3,708,686 385.5M USD −67.4% reduced Q3 2014 2 quarters
SNDK Sandisk < 0.1% 202,840 19.9M USD −90.7% reduced Q3 2014 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Health Care 15.0%
  • Financials 9.5%
  • Technology 5.9%
  • Consumer Staples 5.4%
  • Materials 5.0%
  • Industrials 3.3%
  • Real Estate 2.6%
  • Consumer Discretionary 2.1%
  • not in our coverage 51.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close